Neogen reported $149.5M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Agilent USD 2.29B 20M Jun/2026
Bio-Rad Laboratories USD 969.1M 7.8M Sep/2026
Cerus USD 100.8M 12.37M Dec/2025
Danaher USD 9.05B 945M Sep/2026
Idexx Laboratories USD 1.26B 23.44M Sep/2026
Illumina USD 1.16B 422M Sep/2026
Integra LifeSciences USD 329M 1.88M Sep/2026
Neogen USD 149.5M 8.7M Jun/2026
OraSure Technologies USD 25.12M 18.96M Jun/2026
Pacific Biosciences Of California USD 66.59M 2.21M Sep/2026
Quidel USD 1.07B 73.7M Sep/2026
Rockwell Medical USD 10.95M 259K Jun/2025
STAAR Surgical USD 75.54M 2.15M Sep/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Utah Medical Products USD 3.5M 907K Mar/2026
Zoetis USD 2.68B 621M Sep/2026